Business Wire

Endace and Artiza Networks Partner to Deliver Cybersecurity and Defense Solutions to the Japanese Market

8.7.2026 14:00:00 EEST | Business Wire | Press release

Share

Endace, a leading provider of always-on packet capture, network visibility, and packet forensics solutions, and Artiza Networks, Inc. ("Artiza"), a leading provider of telecommunications test, measurement, and network assurance solutions, today announced a partnership to deliver advanced cybersecurity and defense solutions to customers in Japan.

“Artiza is exactly the partner we have been looking for to satisfy demand in Japan, with the right balance of expertise, and market reach,” said Stuart Wilson, CEO of Endace.

Through this partnership, Artiza will offer Endace's packet capture, network recording, and packet forensics solutions to customers in Japan, including telecommunications operators, enterprises, government agencies, defense organizations, and critical infrastructure providers.

Endace's EndaceProbe Analytics Platform provides highly scalable, always-on packet capture and recording capabilities across a wide range of network environments, including enterprise networks, data centers, telecommunications networks, on-premises infrastructures, hybrid cloud environments, and public cloud deployments. The platform enables Security Operations Center (SOC) and Network Operations Center (NOC) teams to investigate cybersecurity incidents, network performance issues, and operational anomalies by providing access to complete packet-level evidence.

Endace solutions integrate with a broad range of cybersecurity and network monitoring platforms, providing direct access to definitive packet evidence required for incident investigation, threat hunting, and root-cause analysis.

By making complete packet-level evidence available to security and operations teams, Endace helps organizations improve the effectiveness of cybersecurity investigations and network performance analysis.

In addition, Endace solutions have achieved important security certifications and approvals, including NIST FIPS 140-3 validation, Common Criteria / NIAP certification, and inclusion on the U.S. Department of Defense Information Network Approved Products List (DoDIN APL). These achievements demonstrate compliance with some of the world's most demanding cybersecurity requirements for government, defense, and critical infrastructure environments.

By combining Endace's advanced packet visibility and packet forensics technologies with Artiza's strong presence in the Japanese telecommunications and technology markets, the two companies will work together to support organizations seeking enhanced cybersecurity, operational resilience, and network assurance capabilities.

About Endace

Endace’s scalable, always-on packet capture gives Network Operations and Security teams the deep visibility they need for fast, accurate incident investigation with rich forensic evidence at their fingertips from all their tools. EndaceProbes provide enterprise-class packet sniffing in on-prem, public and private cloud environments, with rapid, centralized search and one-click access to full pcap data from leading security and performance solutions (including Microsoft, Palo Alto Networks, Fortinet, Cisco, Splunk, Elastic, and many others). Analyze network traffic using a single, unified console across all on-prem, private, or public cloud infrastructure for total hybrid cloud visibility. Capture every packet. See every threat. www.endace.com

About Artiza Networks

Artiza Networks is the leader in radio access network (RAN) and core network (CN) testing for 3G, 4G, and 5G. For over 30 years, Artiza has collaborated with the industry's top vendors and operators in testing the RAN and core network nodes of the world's most advanced cellular networks. With extensive engineering resources including PCB and FPGA/DSP development, award-winning customer support, and a sales force versed in mobile network technology, Artiza meets the full range of customer needs through innovative, in-house development of products and solutions.

Artiza Networks, Inc. (TSE 6778)
Established: 27 December 1990
www.artizanetworks.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260708462599/en/

Contacts

For more information, contact:

Endace
Email: pr@endace.com
Phone:
Mark Evans, mobile +64-21-494 850 – New Zealand / APAC
Kimber Smith-Fidler, mobile +1 775 298 5260 – USA / North America
Leah Jones (The CommsCo), mobile +44 203 697 6680 – UK / EMEA

Artiza Networks
Network Product Business Operations
+81-42-529-3494
Contact: https://www.artizanetworks.com/contact.html#contactForm -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.artizanetw
orks.com%2Fcontact.html%23contactForm&esheet=54566111&newsitemid=20260708462599&
lan=en-US&anchor=https%3A%2F%2Fwww.artizanetworks.com%2Fcontact.html%23contactFo
rm&index=5&md5=8c4ea1dbb727fb3caf2797f5967b2ac2

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fastly Joins DIMPACT to Collaborate on Digital Sustainability8.7.2026 15:00:00 EEST | Press release

Fastly, Inc. (NASDAQ: FSLY), a leading global edge cloud platform, today announced it has become a participant of DIMPACT, the coalition of leading organizations working to align industry changemakers and policymakers around meaningful, science-based solutions that reduce the environmental impacts of serving digital media products. As the first edge cloud platform provider to join the coalition, Fastly brings critical, real-world edge network data and infrastructure expertise and a transparent approach to emissions calculation and reporting to help major media, streaming, and publishing companies understand and optimize their digital carbon footprints. “We’re thrilled to welcome Fastly to the DIMPACT initiative. Their participation strengthens DIMPACT's ability to advance a more accurate, data-driven approach to measuring and reducing digital emissions,” said Jason Bell, Director at SLR Consulting and Executive Sponsor of DIMPACT. “Accurately calculating digital emissions requires a de

PubNub Introduces Blocks.ai: The Control Plane and Network Layer For AI Agents8.7.2026 15:00:00 EEST | Press release

PubNub introduces Blocks.ai today, a global network to connect and control agents across all agent frameworks, providers, and APIs. Blocks.ai lets developers reach their existing AI agents regardless of where they are hosted. Blocks Network supports all AI agent use cases without opening inbound ports, setting up tunnels, changing DNS, or modifying firewall rules. For more than a decade, PubNub has been the infrastructure and platform for real-time connectivity supporting billions of devices, now, PubNub delivers Blocks Network connecting the Internet of Agents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708521206/en/ AI agents have become increasingly critical to businesses who want control over their models, code, and data. But once those agents are running locally or behind a firewall, making them reachable from custom frontends can require brittle infrastructure work. This is a key reason why McKinsey estimates th

STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development8.7.2026 15:00:00 EEST | Press release

STEMCELL Technologies and the Centre for Commercialization of Regenerative Medicine (CCRM) today announced a partnership to expand access to high-quality human induced pluripotent stem cell (iPSC) starting materials, giving cell therapy developers worldwide a faster, lower-risk path from research to the clinic. Under the agreement, STEMCELL will manufacture and distribute research-use-only (RUO) iPSC lines derived directly from LineaBio's Good Manufacturing Practices (GMP) iPSC lines, and will offer the matched GMP lines to developers worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708212795/en/ Partnership pairs GMP-manufactured iPSC lines with matched RUO equivalents, giving developers well-characterized, donor-eligible starting materials from early research through clinical development. Supporting comparability data for the RUO and GMP lines to be presented at the 2026 ISSCR Annual Meeting in Montréal, Canada

LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 15:00:00 EEST | Press release

The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer of its kind, combining quantum error correction with NISQ qubits. The system will be delivered in 2027, followed by a series of upgrades delivered in multiple phases with an increasing number of logical qubits. The IQM Halocene H4 and the upgraded systems will enable LUMI consortium users, for the first time, to develop and implement Quantum Error Correction (QEC) concepts on a world-leadi

Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 15:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manifestations, often associated with substantial physical and psychosocial burden, the lack of targeted treatment makes the disease hard to control,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “This Breakthrough Therapy designation demonstrates that enpatoran has the potential to redefine how we approach lupus, by addressing the visible burden of rash, while potentially driving benefit beyond the skin. We look forward to working with the FDA to potentially bring this much-needed option to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye